Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma

Hugo J. A. Adams; Thomas C. Kwee

doi:10.1007/s00259-017-3771-8

Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma

Hugo J. A. Adams^*, Thomas C. Kwee

^*Corresponding author voor dit werk

Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE)

Onderzoeksoutput › Academic › peer review

1 Citaat (Scopus)

48 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	1934-1936
Aantal pagina's	3
Tijdschrift	European Journal of Nuclear Medicine and Molecular Imaging
Volume	44
Nummer van het tijdschrift	11
DOI's	https://doi.org/10.1007/s00259-017-3771-8
Status	Published - okt.-2017

Toegang tot document

10.1007/s00259-017-3771-8

Unproven value of end-of-treatment FDG-PET in Hodgkin lymphomaFinal publisher's version, 344 KBLicentie: Taverne

Handle.net

Permanente koppeling

Citeer dit

@article{d5a19d4e856b42cfb7ce0a7e5f351973,

title = "Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma",

keywords = "POSITRON-EMISSION-TOMOGRAPHY, EARLY INTERIM, FREE SURVIVAL, F-18-FDG PET, THERAPY, CRITERIA, DANISH, SCAN",

author = "Adams, {Hugo J. A.} and Kwee, {Thomas C.}",

year = "2017",

month = oct,

doi = "10.1007/s00259-017-3771-8",

language = "English",

volume = "44",

pages = "1934--1936",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

number = "11",

}

TY - JOUR

T1 - Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma

AU - Adams, Hugo J. A.

AU - Kwee, Thomas C.

PY - 2017/10

Y1 - 2017/10

KW - POSITRON-EMISSION-TOMOGRAPHY

KW - EARLY INTERIM

KW - FREE SURVIVAL

KW - F-18-FDG PET

KW - THERAPY

KW - CRITERIA

KW - DANISH

KW - SCAN

U2 - 10.1007/s00259-017-3771-8

DO - 10.1007/s00259-017-3771-8

M3 - Comment/Letter to the editor

SN - 1619-7070

VL - 44

SP - 1934

EP - 1936

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 11

ER -